SCHEMBL26667409

SCHEMBL26667409

O=C(O)NCCC[C@@H](c1nnc(-c2ccc(Cl)cc2)o1)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 3/20 0.43
LMNA P02545 2/20 0.43
HPGD P15428 4/20 0.42
S1PR3 Q99500 1/20 0.41
PTGS2 P35354 1/20 0.39
HSD17B10 Q99714 3/20 0.39
NPC1 O15118 2/20 0.39
TSHR P16473 2/20 0.39
RAB9A P51151 2/20 0.39
POLB P06746 2/20 0.39
TP53 P04637 2/20 0.39
MAPT P10636 5/20 0.38
KDM4E B2RXH2 5/20 0.38
ALDH1A1 P00352 2/20 0.38
NFKB1 P19838 1/20 0.38
CASP3 P42574 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26667416 1.00 USP2 (0.43) USP2LMNAHPGDS1PR3PTGS2
SCHEMBL24302524 0.87 LMNA (0.41) USP2LMNAHPGDTSHRMAPT
SCHEMBL29025574 0.87 LMNA (0.41) USP2LMNAHPGDTSHRMAPT
SCHEMBL30504318 0.87 LMNA (0.41) USP2LMNAHPGDTSHRMAPT
SCHEMBL29025559 0.82 USP2 (0.43) USP2LMNAHPGDS1PR3HSD17B10
SCHEMBL29025560 0.82 USP2 (0.43) USP2LMNAHPGDS1PR3HSD17B10
SCHEMBL30504316 0.82 USP2 (0.43) USP2LMNAHPGDS1PR3HSD17B10
SCHEMBL29025571 0.79 LMNA (0.41) USP2LMNAHPGDS1PR3HSD17B10
SCHEMBL26667489 0.76 HDAC1 (0.41) USP2LMNANPC1RAB9ATP53
SCHEMBL26667492 0.76 HDAC1 (0.41) USP2LMNANPC1RAB9ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381146-A1 SUBSTITUTED HETEROARYL COMPOUNDS AND USE THEREOF HELIOS HUAMING BIOPHARMA CO., LTD. (CN) 2023-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381146-A1 SUBSTITUTED HETEROARYL COMPOUNDS AND USE THEREOF SSB, BTK, PADI6 USP2 3236/4885LMNA 3065/4885HPGD 2296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.